Clinical trial
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia…
NCT00289900 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00289900 |
|---|---|
| Title | Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) |
| Official title | A Multicenter, Randomized, Double-Blind, Parallel Group, 12 Week Study to Evaluate the Efficacy and Safety of MK0524B Versus Atorvastatin in Patients With Mixed Hyperlipidemia |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mixed Hyperlipidemia |
| Intervention type | Drug |
| Interventions | MK-0524A, Atorvastatin, Simvastatin |
| Enrollment | 2,340 |
| Start date | Jan 24, 2006 |
| Primary completion | Aug 6, 2010 |
| Completion | Aug 6, 2010 |
| First posted | Feb 10, 2006 |
| Last update posted | Aug 31, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: